Smallest-scale technologies for a big medical impact

With the further development of the Center for Micro and Nanochemistry and Engineering (Cµ), the University of Siegen is boosting medical research into aspects of (bio)chemical sensor technology in the School of Science and Technology. The newly approved projects have a common focus on sensor technology and materials for the detection of and effective measures against bacteria and antimicrobial resistance. The NAPARBA project coordinated by Prof. Dr. Holger Schönherr was launched on November 1, 2020. It is supported by the Southeast Asia – Europe Joint Funding Scheme on Research and Innovation. The scientists are examining nanoparticle-based detection of antibiotic-resistant bacteria. Project partners are Koç University in Istanbul (Turkey) and the Research Centre of Chemistry – LIPI (Indonesia).

Dr. Schönherr is also coordinating another project. TARGET-THERAPY is scheduled to start in early 2021. This research project, which in Siegen also involves Prof. Dr. Ulrich Jonas and Dr. Mareike Müller, is dedicated to the targeted therapy of pathogenic bacteria in the lung by means of photodynamic treatment. Its goal is to significantly improve the treatment of infections in biofilms in the lung caused by the multiresistant pathogen P. aeruginosa, which is classed by the WHO as highly critical. Click here to read more
Hier mehr in der deutschen Version lesen.